| Prev Close | 273.39 |
| Day Low/High | 313.00 / 350.15 |
| 52 Wk Low/High | 98.65 / 497.49 |
Moderna, Inc. (MRNA)
329.63
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 405.45B |
| Market Cap | 110.85B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan
PFE has created what appears to potentially be the most effective antiviral for those already infected.
Variant's Grand Slam, Good Data, Going With the ETF Flow, Eye on Black Friday
Plus, a thought on how the Fed could approach tapering going forward.
5 Reasons to Bet on Biotech
Small-cap biotech names are seeing dramatic, widespread declines, creating a liquidation sale for investors.
Hotel California
* What's to like? Very little.. * Though the averages have held up (thank you "Nifty Seven"), a look under the hood reveals a dismal picture of broken stocks and charts "Last thing I remember, I was Running for the door I had to find the passage ba...
Moderna's Patent Credit, Palantir and ARK, Musk Sells Tesla as EV Stocks Climb
Plus, the intersection of rising inflation and a slowing velocity of money give us reason for pause.
Putting Together an End-of-Year Trading Strategy
Let's review areas that are hot, those that are not, and how to position though January.
Options Play of the Week: Dipping Into Dynavax
Knee-jerk reactions to earnings results can create attractive opportunities.
Moderna's Shots Block COVID, but Its Shares Now Have Risky Side Effects
Let's see how far this pharma name could fall, even as it plays a leading role in the battle against the pandemic.
Buying Moderna Now Could Be Akin to Trying to Catch a Falling Knife
Here's what traders can do.
Programming Note
I will be out between 9-10 am as I am getting a Moderna booster.
Black Monday Recollections, Bitcoin ETF Launch, Fed Numbers, FDA, Disney's Dip
While cryptocurrencies are indeed an asset class, and they are divisible, they do not serve as a medium of exchange, and remain unproven as a store of value.
Super Thursday, Filling Gaps, Crypto Regulator Talk, Amazing Alcoa, AMD Love
Plus, an FDA advisory panel gives a unanimous boost to a Moderna booster shot and Boeing slumps on a negative news report.
These Microcaps Are Making Some Big Noise
I attended the LD Micro Conference in Los Angeles. Here's what I found out.
Where the S&P and Nasdaq Stand, The New Green Team, Trading Southwest and Pfizer
With earnings season starting in earnest Wednesday, both indexes have offered investors nothing but lower highs coupled with lower lows since the start of September.
A Series of Fortunate Events, Fiscal Cliff, Powell's Prospects, 4 Trading Notes
Market volatility could spike in late November/early December just as liquidity walks away. Keep that in mind.
Dios Mio, Man
Dios Mio, Man  Moderna , a FINTV fave is now -$200/share from its high. Will the bulls take ownership? Rhetorical question, I suppose.
Blue Monday, Gathering 3 'Roses', Ugly Nasdaq, Fossil Fuels, Trading Amazon
In a real bear market, one that persists, volumes will dry up. Corrections are violent and volatile. That's where we are now.
Booster Club
As you mark your October calendar for what I shared earlier, also keep your eyes on Oct. 14-15. Those are the days a panel of FDA advisors will meet to discuss whether to recommend booster shots of Covid-19 vaccines from Moderna and Johnson & Johnso...
Clinically Speaking: 6 Stocks Behind the Scenes at Drug Trials
Investors are increasingly looking to the companies involved in clinical trials. Here are six favorite names in this space.
Fed Speaks, Taper Timeline, Dot Fantasy, Evergrande, DC Circus, Booster Stocks
It was as if markets heard what they wanted to hear, when it was actually much more simple: markets heard exactly what they had anticipated.
Minty Fresh Breadth, Market Streaks, Inflation, Vaccine Plays, An AMD Warning
The New York Fed's August Survey of Consumer Expectations could be problematic.
A Day Never to Forget, Red-Hot Debt Market, Moderna Marches On, Biden Thumbs Up
Plus, Zscaler largely delivers for its owners with its latest results.
Moderna Poised to Get a Boost
The charts and indicators tell us the correction is over.
Stall Speed? Jobs Gut Punch, Taiwan Worries, Mu Variant, Trading AbbVie
What if areas of expected growth in labor market demand moving forward do not materialize?
Energy Sector, Powell Speak, Labor Market, Booster Shots, Trading Kratos Defense
While all cyclical equity sectors did well, last week's push into more economically sensitive equities was indeed led by the energy sector.
A Senseless Sad Day, Fed Taper Talk, COVID and Kids, To Vax or Not to Vax
Plus, a look at Dollar General and Peloton Interactive, which both disappointed with their announcements on Thursday.
Market Fatigue, Treasuries Death Cross, Meme Memo, Taiwan Semi, Oh What a Night
I could be wrong, but as far as I can tell, nobody else is telling the story about the sudden movement in these yields.
Jim Cramer: I'm 'Fed' Up With This Lazy Investing Advice
The whole notion of the grand inquisitor Fed is out of whack with reality. Here's what you should be watching, instead.
Comirnaty, Semiconductor-Palooza, Infrastructure Snag, Trading Cybersecurity
The fiscal football remains a greater threat this week than anything Fed Chair Jerome Powell says on Zoom this Friday.
Henri, Fiscal and Monetary Uncertainty, Vaccine Update, Trading Nvidia and AMD
Investors come into this week with 'all eyes' on the Kansas City Fed's economic symposium come week's end.
